BioCentury
ARTICLE | Clinical News

Fentora regulatory update

July 25, 2011 7:00 AM UTC

FDA approved a REMS for Fentora fentanyl effervescent buccal tablet from Cephalon to manage breakthrough pain in opioid-tolerant patients with cancer. Under the REMS, pharmacy and healthcare professio...